Disclosure. Learning Objectives 6/4/2014. Medication Adherence: Challenges and Opportunities

Size: px
Start display at page:

Download "Disclosure. Learning Objectives 6/4/2014. Medication Adherence: Challenges and Opportunities"

Transcription

1 Medication Adherence: Challenges and Opportunities Jessica W. Skelley, Pharm D., BCACP Assistant Professor of Pharmacy Practice McWhorter School of Pharmacy, Samford University Disclosure I, Jessica Skelley, DO NOT have a financial interest/arrangement or affiliation with one or more organizations that could be perceived as a real or apparent conflict of interest in the context of the subject of this presentation. DO NOT anticipate discussing the unapproved/investigative use of a commercial product/device during this activity or presentation. Learning Objectives At the end of this program, attendees should be able to: Identify benefits of medication adherence, including those related to financial and health considerations. Recognize barriers to medication adherence for different patient demographics and disease states. Develop strategies to promote adherence within the general population, and special populations. List existing community resources and technology to assist in promoting medication adherence. 1

2 Outline Background Causes of nonadherence Assessing adherence Potential solutions Resources Introduction Drugs don t work in patients who don t take them. C. Everett Koop, MD Audience Response Answer yes or no to the following questions: I ve provided care to a patient where I ve Ive noticed adherence was an issue. I ve questioned a patient about their medication adherence. What was the patient s response to this interaction? 2

3 Background Adherence has been defined as the active, voluntary, and collaborative involvement of the patient in a mutually acceptable course of behavior to produce a therapeutic result. 1 Adherence vs compliance Adherence vs persistence 1. Delamater AM. Improving patient adherence. Clin Diabetes. 2006;24: Background Prescriptions never filled: 20-30% Patients with chronic medical illnesses adherent with treatment only 50% of time 1 Dramatic decrease after 6 months Examples: 56% of asthma patients nonadherent to inhaler therapy % patients discontinue statin use after 2 years 3 1.Variations in patients adherence to medical recommendations: a quantitative review of 50 years of research. Medical Care. 2004;42(3): Jackevicius CA, Mamdani M, Tu JV. Adherence with statin therapy in elderly patients with and without acute coronary syndromes. JAMA. 2002;288: Background Clinical trials: average adherence rates of only 43-78% among patients receiving treatment for chronic conditions 1,2 General rate defined in literature as good adherence: 80% 1. Cramer J, Rosenheck R, Kirk G, Krol W, Krystal J. Medication compliance feedback and monitoring in a clinical trial: predictors and outcomes. Value Health. 2003;6: Claxton AJ, Cramer J, Pierce C. A systematic review of the associations between dose regimens and medication compliance. Clin Ther 2001;23:

4 Background Patterns in medication use through electronic monitoring: Most deviations occur as omission of doses or delays in timing of dose White coat adherence Background Six general patterns of medication use for chronic illnesses: Close to perfect adherence Take nearly all doses, but with some timing irregularity Miss an occasional single day s dose and some timing inconsistently Take drug holidays 3-4 times annually, and occasional omissions of doses Have a drug holiday monthly or more often, with frequent dose omissions Take few or no doses while giving impression of good adherence Background Poor adherence: causes approximately 33% to 69% of medication-related hospitalizations adds an estimated $290 billion to overall health-care spending annually creates a $188 billion revenue gap in US for industry, PBM s and pharmacies 4

5 Background Audience Response Which of the following is NOT associated with decreased adherence? A. Socioeconomic status B. Side effects of treatment C. Poor provider-patient relationship D. Depression Causes of Nonadherence Intentional nonadherence Results from planned action due to reasons such as side effects, belief medication is harmful or ineffective, etc. Unintentional nonadherence Results from unplanned action due to reasons such as forgetfulness, complex regimen, etc. 5

6 Causes of Nonadherence Osterberg L, Blaschke T. N Engl J Med 2005;353: Causes of Nonadherence Causes may vary based on factors related to age and health status Race, sex, and socioeconomic status have not been consistently associated with levels of adherence Osterberg L, Blaschke T. N Engl J Med 2005;353:

7 Assessing Adherence Direct: DOT, measurement of drug concentration Indirect: asking patient, assessing clinical response, pill counts, refill history, electronic monitoring Potential confounders for all! Assessing Adherence Pharmacy data: Medication possession ratio: # days medication supplied within refill interval number of days in refill interval Max value is >1: accounts for oversupply Proportion of days covered: total days all drug(s) available days in follow-up period Day is only counted if all medications are available that day (max value is 1) Both correlate well with quantity of taken doses, but not timing of doses Assessing Adherence 7

8 Assessing Adherence Questionnaires Morisky Medication Adherence Questionnaire (aka, MAQ, MMAS-4, Morisky-4; also an 8 question version) Self-Efficacy for Appropriate Medication Use Scale (SEAMS) Brief Medication Questionnaire (BMQ) Medication Adherence Rating Scale (MARS) Patient Empowerment Program Assessing Adherence Patient Empowerment Program: (look for PEP pharmacy in app store) Free app for ipad designed for use in pharmacy 3-5 minute self-assessment that identifies top 3 dimensions affecting adherence 8

9 Assessing Adherence Choosing adherence scale based on disease of interest: Metabolic disorders: HTN, dyslipidemia, DM MAQ (shortest to administer), SEAMS (assesses self-efficacy), BMQ (diabetes only), Hill-Bone Compliance Scale (hypertension in predominantly black populations) Mental health: Schizophrenia, psychosis, depression MARS (schizoprenia and psychosis), BMQ (depression) Lavsa SM et al. J Am Pharm Assoc. 2011;51(1):90-94 Assessing Adherence In general practice, the simplest and most practical way to assess adherence is to ask patients nonjudgmentally how often they miss doses. Potential Solutions Unimodal vs multimodal solutions Interventions Should be Patient-Tailored Behavior-related Daily alerts 90 days medication supplies Automatic renewals Clinical Questions or concerns about medication Pharmacist consultation Linguistically and culturally appropriate Cost-related Payment assistance programs Lower cost medication alternatives Lower cost pharmacy option 9

10 Potential Solutions Simple dosing helps to maximize adherence Osterberg L, Blaschke T. N Engl J Med 2005;353:4877. Potential Solutions Community pharmacy-run programs Home visits: (ex: Moose Pharmacies in NC) 90 day fills Chain store programs (ex: Rite Aid) Medication synchronization programs Star ratings and adherence programs Potential Solutions Medication synchronization programs Prescriptions filled on the same day each month Provides intentional, monthly encounter with pharmacist to review medications Patients averaged >100 additional days of therapy annually 30% more likely to take medications as prescribed 10

11 Medication synchronization programs Patients averaged >100 additional days of therapy annually 30% more likely to take medications as prescribed Potential Solutions Star Ratings: Medicare Part D/Advantage plans Plans tracking data to determine what pharmacies can participate in preferred networks Providing financial incentives for good patient outcomes in areas such as adherence Potential Solutions Other strategies: Emphasize the value of the regimen and the effect of adherence Elicit patient s feelings about his or her ability to follow the regimen, and if necessary, design supports to promote adherence Provide simple, clear instructions and simplify the regimen as much as possible Encourage the use of a medicationtaking system (pill box, etc) Customize the regimen in accordance with the patient s wishes 11

12 Potential Solutions Other strategies, cont. Obtain help from family members, friends, and community services when needed Reinforce desirable behavior and results when appropriate Consider more forgiving medications when adherence appears unlikely: Medications with long half lives Depot (extended release medications) Transdermal medications Patient Resources Smartphone Apps Study published in JAPhA in 2013 by Dayer, et al. on available adherence apps 160 adherence apps were identified and ranked Among the apps, MyMedSchedule, MyMeds, and RxmindMe rated highest for ease of use and reminder features Patient Resources 12

13 Patient Resources Patient Resources Adherence Aids: nce/adherence_aids.pdf Script your future: Provides wallet cards, medicine management tools, and medication guides for common disease states Educator Resources NCPA Educator Toolkit: dherence-educators-toolkit Teaches classroom and experiential students about adherence 13

14 Questions? 14

To Take or Not To Take?

To Take or Not To Take? To Take or Not To Take? Assessment Question How do the terms adherence & compliance differ? 1. The terms are synonymous 2.Adherence assumes collaboration between patient & provider while compliance suggests

More information

OR OTHER RELATIONSHIP(S) DISCLOSURE:

OR OTHER RELATIONSHIP(S) DISCLOSURE: Gregory Roth, MD DISCLOSURE DECLARATION Medication Adherence in Cardiovascular Disease: Drugs Don t Work in Patients Who Don t Take Them FINANCIAL OR OTHER RELATIONSHIP(S) DISCLOSURE: St. Charles Medical

More information

ADHERTENCE AND COMPLIANCE TO TREATMENTS

ADHERTENCE AND COMPLIANCE TO TREATMENTS ADHERTENCE AND COMPLIANCE TO TREATMENTS Sobhi DADA, MD, FACC, FESC Consultant cardiology Hammoud Hospital- University medical center Saida, Lebanon Adherence Mosby s Medical Dictionary defines adherence

More information

Assessing Medication Adherence

Assessing Medication Adherence Assessing Medication Adherence Dr. Lauren Hanna and Dr. Delbert Robinson Northwell Health National Council for Behavioral Health Montefiore Medical Center Northwell Health New York State Office of Mental

More information

Improving Adherence to Chronic Medications: The Physicians Role and How 340b Can Help

Improving Adherence to Chronic Medications: The Physicians Role and How 340b Can Help Improving Adherence to Chronic Medications: The Physicians Role and How 340b Can Help William Shrank MD MSHS Division of Pharmacoepidemiology & Pharmacoeconomics Harvard Medical School wshrank@partners.org

More information

Hypertension and the Challenge of Adherence. Geneva Clark Briggs, Pharm.D., BCPS

Hypertension and the Challenge of Adherence. Geneva Clark Briggs, Pharm.D., BCPS Hypertension and the Challenge of Adherence Geneva Clark Briggs, Pharm.D., BCPS Outline Brief overview of HTN and pharmacologic therapies Role of pharmacists in collaboration with patients and physicians

More information

Cost-Effective Process to Improve Drug Adherence for Medicare 5-Star

Cost-Effective Process to Improve Drug Adherence for Medicare 5-Star Cost-Effective Process to Improve Drug Adherence for Medicare 5-Star HEALTH ALLIANCE PLAN Presented by Vanita K. Pindolia, Pharm.D. VP, Ambulatory Clinical Pharmacy Programs_PCM Medicare 5-Star Rating

More information

Digital Technologies: The Solutions to Poor Medication Adherence?

Digital Technologies: The Solutions to Poor Medication Adherence? Digital Technologies: The Solutions to Poor Medication Adherence? Jeffrey Mesaros, PharmD Annual Meeting & Exposition Seattle, Washington March 22-25 1 Disclosures The views and opinions expressed in the

More information

Medication Adherence

Medication Adherence Medication Adherence 1-30-15 Presented by: Alexander Luong, Pharm.D. Candidate 2015 University of the Pacific Preceptor: Dr. Craig Stern Pharm.D., MBA President Pro Pharma Pharmaceutical Consultants, Inc

More information

MEDICATION ADHERENCE: WE DIDN T ASK & THEY DIDN T TELL

MEDICATION ADHERENCE: WE DIDN T ASK & THEY DIDN T TELL MEDICATION ADHERENCE: WE DIDN T ASK & THEY DIDN T TELL JENNIFER BUSSELL MD FACP INSTITUTE FOR HEALTHCARE IMPROVEMENT 15 TH ANNUAL INTERNATIONAL SUMMIT ON IMPROVING PATIENT CARE IN THE OFFICE PRACTICE AND

More information

Tools for Targeting High Risk Patients in Your Practice. Statement of Disclosure

Tools for Targeting High Risk Patients in Your Practice. Statement of Disclosure Tools for Targeting High Risk Patients in Your Practice Joseph Vande Griend, PharmD, BCPS, CGP Assistant Professor, University of Colorado Departments of Clinical Pharmacy and Family Medicine Skaggs School

More information

Concordance of Pharmacist Assessment of Medication Nonadherence With a Self-Report Medication Adherence Scale

Concordance of Pharmacist Assessment of Medication Nonadherence With a Self-Report Medication Adherence Scale Chapman University Chapman University Digital Commons Pharmacy Faculty Articles and Research School of Pharmacy 10-13-2014 Concordance of Pharmacist Assessment of Medication Nonadherence With a Self-Report

More information

INTERNATIONAL RESEARCH JOURNAL OF PHARMACY ISSN Research Article

INTERNATIONAL RESEARCH JOURNAL OF PHARMACY  ISSN Research Article INTERNATIONAL RESEARCH JOURNAL OF PHARMACY www.irjponline.com ISSN 2230 8407 Research Article ASSESSMENT OF MEDICATION ADHERENCE AND FACTORS AFFECTING TO MEDIACTION ADHERENCE IN ASTHMA PATIENTS BY CLINICAL

More information

Rethink. Adherence. David D. Pope, PharmD, CDE Editor-in-Chief, CreativePharmacist.com Brands

Rethink. Adherence. David D. Pope, PharmD, CDE Editor-in-Chief, CreativePharmacist.com Brands Rethink. Adherence. David D. Pope, PharmD, CDE Editor-in-Chief, CreativePharmacist.com Brands Objectives Identify patient barriers to medication adherence. Describe the clinical and economic impact of

More information

Medication Adherence: How Much is Enough?

Medication Adherence: How Much is Enough? Medication Adherence: How Much is Enough? Terrence F. Blaschke, M.D. Senior Program Officer, GH Discovery and Translational Sciences Bill and Melinda Gates Foundation Professor of Medicine and of Molecular

More information

Getting Hypertension Under Control

Getting Hypertension Under Control Getting Hypertension Under Control Learning Objectives EXPLAIN the factors involved in patient medication non-adherence. OUTLINE the results of studies focusing on medication adherence issues in patients

More information

How to Conduct an Effective Medication Therapy Management Session in the Community Pharmacy

How to Conduct an Effective Medication Therapy Management Session in the Community Pharmacy How to Conduct an Effective Medication Therapy Management Session in the Community Pharmacy Presented by: Dale Christensen, University of North Carolina Susmita Chavala, Humana Ed Staffa, Community MTM

More information

Rich Segal, R.Ph., Ph.D. Professor and Associate Dean University of Florida

Rich Segal, R.Ph., Ph.D. Professor and Associate Dean University of Florida Exploring Barriers to Medication Adherence and Strategies for Improving Adherence for Asthma Rich Segal, R.Ph., Ph.D. Professor and Associate Dean University of Florida Presentation Objectives Understand

More information

Patient Adherence Claire Neely, MD

Patient Adherence Claire Neely, MD Patient Adherence Claire Neely, MD Care of Mental, Physical, and Substance use Syndromes! The project described was supported by Grant Number 1C1CMS331048-01-00 from the Department of Health and Human

More information

ENSURING EXCELLENCE IN PRESCRIBING FOR OLDER ADULTS

ENSURING EXCELLENCE IN PRESCRIBING FOR OLDER ADULTS ENSURING EXCELLENCE IN PRESCRIBING FOR OLDER ADULTS Philip J. Schneider, MS, FASHP The University of Arizona College of Pharmacy Learning Objectives: Describe the medication-use system and all interdependent

More information

Leverage Healthcare Technology Applications to Improve Primary Nonadherence.

Leverage Healthcare Technology Applications to Improve Primary Nonadherence. Leverage Healthcare Technology Applications to Improve Primary Nonadherence. Page 2 Medication adherence starts with assessing a patient s opportunity for having positive outcomes on a specific therapy.

More information

PHARMACIST INVOLVEMENT IN HIV CARE. Alftan D. Dyson, Pharm.D., BCACP, AAHIVP Clinical Pharmacist, Medical Advocacy and Outreach

PHARMACIST INVOLVEMENT IN HIV CARE. Alftan D. Dyson, Pharm.D., BCACP, AAHIVP Clinical Pharmacist, Medical Advocacy and Outreach PHARMACIST INVOLVEMENT IN HIV CARE Alftan D. Dyson, Pharm.D., BCACP, AAHIVP Clinical Pharmacist, Medical Advocacy and Outreach Objectives Describe the unique role of pharmacists in patient education and

More information

9/25/15. Pharmacy Quality Measures: Financial Support. Learning Objectives. Speaker Disclosure. Access to Preferred Networks and Clinical Performance

9/25/15. Pharmacy Quality Measures: Financial Support. Learning Objectives. Speaker Disclosure. Access to Preferred Networks and Clinical Performance Pharmacy Quality Measures: Action Steps for Improvement Financial Support Financial support was provided for this activity through an unrestricted grant from Health Mart Systems, Inc. Christine Jacobson

More information

Κώστας Τσιούφης Iπποκράτειο Γ.Ν.Α

Κώστας Τσιούφης Iπποκράτειο Γ.Ν.Α Χρόνιες παθήσεις, παράλληλη φαρμακευτική αγωγή και συμμόρφωση στη θεραπεία σε ασθενείς με συννοσηρότητα Ο ρόλος της πολυφαρμακίας και των πολλαπλών θεραπειών. H συμμόρφωση στη θεραπεία του ασθενή με συννοσηρότητες.

More information

How to Make Taking Your Medications Easier

How to Make Taking Your Medications Easier How to Make Taking Your Medications Easier Daniel Solomon, MD, MPH Candace Feldman, MD, MPH Division of Rheumatology Brigham and Women s Hospital Harvard Medical School Medications often confuse patients

More information

A&M Care Prescription Drug Program Express Scripts Holding Company. All Rights Reserved.

A&M Care Prescription Drug Program Express Scripts Holding Company. All Rights Reserved. A&M Care 2018 2019 Prescription Drug Program 1 Prescription Drug Benefits Annual Deductible Out of Pocket Maximum Access Options Retail 30 Day Supply: Refills allowed as prescribed. (Good option for new

More information

Pediatric Adherence for the School Nurse

Pediatric Adherence for the School Nurse Pediatric Adherence for the School Nurse Eve-Lynn Nelson, Ph.D. Assistant Director, Research KU Center for TeleMedicine (913) 588-2413; enelson2@kumc.edu Generously sponsored through a grant from the Health

More information

3/6/2017. Grassroots Strategies for Improving Adherence. Learning Objectives

3/6/2017. Grassroots Strategies for Improving Adherence. Learning Objectives Grassroots Strategies for Improving Adherence Amy Knight, PhD Director of Rehabilitation Psychology Department of Physical Medicine & Rehabilitation University of Alabama Birmingham Nothing to Disclose

More information

USING MTM TO IMPROVE STAR RATINGS : CASE STUDIES

USING MTM TO IMPROVE STAR RATINGS : CASE STUDIES USING MTM TO IMPROVE STAR RATINGS : CASE STUDIES Sept 13, 2015 Amanda Applegate, PharmD, BCACP Disclosures Nothing to disclose Learning Objectives Describe how MTM can improve star ratings Discuss strategies

More information

A COMPREHENSIVE APPROACH TO MANAGING DIABETES

A COMPREHENSIVE APPROACH TO MANAGING DIABETES A COMPREHENSIVE APPROACH TO MANAGING DIABETES Programs and services to help individuals avoid costly complications and improve outcomes 2 0 1 8 ENTER Supporting each member with targeted guidance and services.

More information

The Un-Special World of Specialty Medications

The Un-Special World of Specialty Medications The Un-Special World of Specialty Medications Manpreet Chahal, PharmD, PhD Oncology Pharmacist, Medical Oncology Associates, Spokane WA Adjunct Clinical Instructor, WSU College of Pharmacy mschahal@wsu.edu

More information

Suzan N. Kucukarslan PhD,* Kristin S. Lee PharmD, Tejal D. Patel PharmD and Beejal Ruparelia PharmD. Abstract

Suzan N. Kucukarslan PhD,* Kristin S. Lee PharmD, Tejal D. Patel PharmD and Beejal Ruparelia PharmD. Abstract An experiment using hypothetical patient scenarios in healthy subjects to evaluate the treatment satisfaction and medication adherence intention relationship Suzan N. Kucukarslan PhD,* Kristin S. Lee PharmD,

More information

Improving Medication Adherence through Collaboration between Colleges of Pharmacy and Community Pharmacies

Improving Medication Adherence through Collaboration between Colleges of Pharmacy and Community Pharmacies Improving Medication Adherence through Collaboration between Colleges of Pharmacy and Community Pharmacies Megan Willson, PharmD, BCPS; Catrina Schwartz, PharmD, BS; Jennifer Robinson, PharmD Spokane,

More information

LAIs and the Challenge of Medication Non-Adherence The Care Transitions Network

LAIs and the Challenge of Medication Non-Adherence The Care Transitions Network LAIs and the Challenge of Medication Non-Adherence The Care Transitions Network Lauren Hanna, M.D. The Zucker Hillside Hospital Northwell Health National Council for Behavioral Health Montefiore Medical

More information

Pharmacy Partnership to Improve Patient Outcomes

Pharmacy Partnership to Improve Patient Outcomes Pharmacy Partnership to Improve Patient Outcomes Minnesota Rural Health Conference Session 2B Ryan M. Harden, MD MS Kendra Metz, Pharm D Sarah Nelson, MD June 25, 2018 Involved Partners Involved Partners

More information

Medicines Management in Chronic Disease

Medicines Management in Chronic Disease Medicines Management in Chronic Disease Professor Ines Krass Faculty of Pharmacy Talk overview Background Challenges Prescribing Efficacy and safety Patient perspectives Adherence Medicines management

More information

Ms. S, age 53, has bipolar disorder,

Ms. S, age 53, has bipolar disorder, How you can simplify your patient s medication regimen to enhance adherence Colleen P. Hall, PharmD, BCPP Vicki L. Ellingrod, PharmD, FCCP Department Editor is produced in partnership with the College

More information

Adherence Concepts for the Cancer Patient. Benyam Muluneh, PharmD, BCOP, CPP

Adherence Concepts for the Cancer Patient. Benyam Muluneh, PharmD, BCOP, CPP Adherence Concepts for the Cancer Patient Benyam Muluneh, PharmD, BCOP, CPP Objectives Discuss the shift from intravenous to oral chemotherapy over the past few decades Assess the various dimensions of

More information

Understanding and Addressing Problematic Medication Adherence

Understanding and Addressing Problematic Medication Adherence Understanding and Addressing Problematic Medication Adherence William H. Polonsky PhD, CDE November 10, 2017 whp@behavioraldiabetes.org RATES OF VERY POOR GLYCEMIC CONTROL HEDIS data from >1000 health

More information

2015 Annual Convention

2015 Annual Convention 2015 Annual Convention Date: Tuesday, October 13, 2015 Time: 8:00 am 9:30 am Location: Gaylord National Harbor Resort and Convention Center, National Harbor 2 Title: Activity Type: Speaker: Benefit from

More information

Understanding Your Patient Care Opportunity Report (PCOR)

Understanding Your Patient Care Opportunity Report (PCOR) Understanding Your Patient Care Opportunity Report (PCOR) Use your January/February 208 PCOR to help improve performance on Medicare Part D Clinical Star Ratings measures. Your January/February 208 Patient

More information

Moving the Needle: How Are We Doing with Patient Adherence to Drug Therapy?

Moving the Needle: How Are We Doing with Patient Adherence to Drug Therapy? Moving the Needle: How Are We Doing with Patient Adherence to Drug Therapy? 2018 Patient Adherence Influence Report By Mike Occhipinti and Linda Morini 2018 Syneos Health. All rights reserved. MOVING THE

More information

Polypharmacy. Polypharmacy. Suboptimal Prescribing in Older Adults. Kenneth Schmader, MD Professor of Medicine-Geriatrics

Polypharmacy. Polypharmacy. Suboptimal Prescribing in Older Adults. Kenneth Schmader, MD Professor of Medicine-Geriatrics Polypharmacy Kenneth Schmader, MD Professor of Medicine-Geriatrics Polypharmacy Definition Causes Consequences Prevention/management Suboptimal Prescribing in Older Adults Overuse Polypharmacy Underuse

More information

16 th Annual IHA Stakeholders Meeting Session 2C

16 th Annual IHA Stakeholders Meeting Session 2C 16 th Annual IHA Stakeholders Meeting Session 2C September 19, 2017 Hilton Los Angeles Airport Thank you to our Content Partner: Medication Adherence AppleCare Pharmacy Programs Confidential and proprietary.

More information

MEDICINES ADHERENCE The Role of the Pharmacist

MEDICINES ADHERENCE The Role of the Pharmacist BROUGHT TO YOU BY MEDICINES ADHERENCE The Role of the Pharmacist Developed by Pfizer 15 May, 2017 This learning module is intended for UK healthcare professionals only. Job code; PP-GEP-GBR-0682. Date

More information

A community pharmacist delivered adherence support service for dyslipidaemia

A community pharmacist delivered adherence support service for dyslipidaemia European Journal of Public Health, Vol. 21, No. 5, 567 572 ß The Author 2010. Published by Oxford University Press on behalf of the European Public Health Association. All rights reserved. doi:10.1093/eurpub/ckq118

More information

Empowering Older Adults On Drug Adherence A Collaborative Service Model. Cheng Po-po, Peggy Nurse Consultant (Gerontology) Yan Chai Hospital, KWC, HA

Empowering Older Adults On Drug Adherence A Collaborative Service Model. Cheng Po-po, Peggy Nurse Consultant (Gerontology) Yan Chai Hospital, KWC, HA Empowering Older Adults On Drug Adherence A Collaborative Service Model Cheng Po-po, Peggy Nurse Consultant (Gerontology) Yan Chai Hospital, KWC, HA Introduction Older adults have multiple pathologies

More information

Medication Therapy Management Solution

Medication Therapy Management Solution Medication Therapy Management Solution A Medicaid Case Report It s often challenging to include evidencebased clinical programs that offer financial benefits. However, pharmacotherapy is central to the

More information

The Value of Walgreens

The Value of Walgreens The Value of Walgreens How Walgreens improves employer health plans through access, quality and lower costs Why millions of patients choose Walgreens And your options to move forward with Walgreens Walgreens

More information

How pharmacy and retail health can support health and wellness. Nancy Gagliano Chief Medical Officer, MC September, 2014

How pharmacy and retail health can support health and wellness. Nancy Gagliano Chief Medical Officer, MC September, 2014 How pharmacy and retail health can support health and wellness Nancy Gagliano Chief Medical Officer, MC September, 2014 2 An important decision for public health Current Health Care Challenges The State

More information

Medication History. Case 1. Case 1. Case 2. Case 1. Four components of prescribing. Charles Mitchell

Medication History. Case 1. Case 1. Case 2. Case 1. Four components of prescribing. Charles Mitchell Medication History Charles Mitchell Director CSEP, University of Queensland Four components of prescribing Information gathering Clinical decision making Monitor and review Communicate decision - prescribe

More information

Medication Therapy Management: Improving Health and Saving Money

Medication Therapy Management: Improving Health and Saving Money Medication Therapy Management: Improving Health and Saving Money Ed Staffa, RPh Vice President, Pharmacy Mirixa Corporation estaffa@mirixa.com July 23, 2008 MTM At A Glance The U.S. health care system

More information

Methods to Diagnose Adherence Status

Methods to Diagnose Adherence Status Methods to Diagnose Adherence Status March 4, 2014 Andrew G Weinstein MD Associate Clinical Professor Pediatrics Jefferson Medical College President, Adherence Management Systems Disclosures President,

More information

Medication Management When Caring for Seniors at Home

Medication Management When Caring for Seniors at Home Medication Management When Caring for Seniors at Home White Paper May 24, 2013 2013 Physician s Choice Private Duty http://private-duty.pchhc.com 1 Proper medication management for seniors who live at

More information

Welcome participants, introduce the expert, and briefly outline today s session.

Welcome participants, introduce the expert, and briefly outline today s session. SESSION CONTENT 5.1 Welcome and outline (2 min) Welcome participants, introduce the expert, and briefly outline today s session. 5.2 Review homework and exercises (15 min) Review participants personal

More information

New inhaler monitoring technologies: what they do and how they are used

New inhaler monitoring technologies: what they do and how they are used Please note, some slides have been removed due to potential copyright restrictions. New inhaler monitoring technologies: what they do and how they are used Paul Colthorpe Global Program Head, Novartis

More information

Introducing ValueOptions Clinical Care Alerts

Introducing ValueOptions Clinical Care Alerts Introducing ValueOptions Clinical Care Alerts January 2013 Agenda What are Clinical Care Alerts? How does it work? What are the benefits? Questions and Answers 2 The Issue of Poor Medication Adherence

More information

Brantley M. Underwood Pharm.D., MBA PGY1 Community Pharmacy Resident Southwestern Oklahoma State University/Walgreen Co

Brantley M. Underwood Pharm.D., MBA PGY1 Community Pharmacy Resident Southwestern Oklahoma State University/Walgreen Co Brantley M. Underwood Pharm.D., MBA PGY1 Community Pharmacy Resident Southwestern Oklahoma State University/Walgreen Co Describe the benefits of using a mobile application as a medication reminder tool

More information

It takes a village: How ACO s can partner with hospitals and community pharmacists to improve care transitions.

It takes a village: How ACO s can partner with hospitals and community pharmacists to improve care transitions. It takes a village: How ACO s can partner with hospitals and community pharmacists to improve care transitions. Brian Hodgkins Pharm.D, FCSHP, FASHP Tim Perlick Pharm.D., CGP Carpooling with Pharmacy October

More information

The Problem of CV Drug Adherence Worldwide

The Problem of CV Drug Adherence Worldwide The Problem of CV Drug Adherence Worldwide Jose M. Castellano Coordinador Investigaciones Clínicas, Centro Nacional de Investigaciones Cardiovascular (CNIC) Instituto de Salud Carlos III, Madrid, Spain

More information

Industry Perspective on Formulation and Packaging Considerations

Industry Perspective on Formulation and Packaging Considerations Industry Perspective on Formulation and Packaging Considerations Ron Ogilvie (Pfizer) EFPIA February 2012 1 Industry Perspective on Formulation and Packaging Considerations Provide an overview of formulation

More information

Non-Adherence: How to Improve the Therapeutic Relationship with Difficult Patients

Non-Adherence: How to Improve the Therapeutic Relationship with Difficult Patients Non-Adherence: How to Improve the Therapeutic Relationship with Difficult Patients Bradford Strijack MD MHSc FRCPC Clinical Assistant Professor University of British Columbia October 7, 2016 None Disclosures

More information

Improving medication compliance with ingestible sensors

Improving medication compliance with ingestible sensors Improving medication compliance with ingestible sensors BHI 505: Digital Health Presentation By: Joseph Miles, PharmD Reference Moorhead, P., Zavala, A., Kim, Y., & Virdi, N. S. (2017). Science and Practice:

More information

Medication Adherence Survey Highlights. A Survey of Upstate New York, 2017

Medication Adherence Survey Highlights. A Survey of Upstate New York, 2017 Medication Adherence Survey Highlights A Survey of Upstate New York, 2017 Survey Methods Method and Design Excellus BCBS commissioned One Research to conduct an online survey of upstate New York adults.

More information

IMPACT OF TREATMENT NONCOMPLIANCE AND ITS EFFECT ON CLINICAL OUTCOME AMONG PATIENTS WITH TYPE II DIABETES BY IMPROVED COMPLIANCE

IMPACT OF TREATMENT NONCOMPLIANCE AND ITS EFFECT ON CLINICAL OUTCOME AMONG PATIENTS WITH TYPE II DIABETES BY IMPROVED COMPLIANCE Page4611 Indo American Journal of Pharmaceutical Research, 2016 ISSN NO: 2231-6876 IMPACT OF TREATMENT NONCOMPLIANCE AND ITS EFFECT ON CLINICAL OUTCOME AMONG PATIENTS WITH TYPE II DIABETES BY IMPROVED

More information

Are Two Antipsychotics Better Than One?

Are Two Antipsychotics Better Than One? Are Two Antipsychotics Better Than One? Lauren Hanna, M.D and Delbert Robinson, M.D. Northwell Health National Council for Behavioral Health Montefiore Medical Center Northwell Health New York State Office

More information

Using CURES to combat prescription drug abuse/misuse

Using CURES to combat prescription drug abuse/misuse Using CURES to combat prescription drug abuse/misuse Speakers Nathan Painter PharmD, CDE Email: npainter@ucsd.edu Rabia Atayee, PharmD, BCPS Email: ratayee@ucsd.edu UC San Diego Skaggs School of Pharmacy

More information

Chronic Obstructive Pulmonary Disease:! Chronic Non-Adherence. Rosemary Henrich, DNP, FNP-BC Amelia Schreibman, DNP, ANP-BC

Chronic Obstructive Pulmonary Disease:! Chronic Non-Adherence. Rosemary Henrich, DNP, FNP-BC Amelia Schreibman, DNP, ANP-BC Chronic Obstructive Pulmonary Disease:! Chronic Non-Adherence Rosemary Henrich, DNP, FNP-BC Amelia Schreibman, DNP, ANP-BC What is COPD: Progressive and irreversible: Exacerbations occur as a result of

More information

Sujita Narayan. Research in Pharmacoepidemiology National School of Pharmacy, University of Otago

Sujita Narayan. Research in Pharmacoepidemiology National School of Pharmacy, University of Otago Sujita Narayan Research in Pharmacoepidemiology (RIPE) @ National School of Pharmacy, University of Otago Medication Possession Ratio (MPR) What is MPR? Measure of adherence Ratio of the no. of doses dispensed

More information

Role of the Clinical Pharmacist in Primary Care

Role of the Clinical Pharmacist in Primary Care Role of the Clinical Pharmacist in Primary Care Amy Kramer, Pharm.D., Manager Clinical Pharmacy Services Kaiser Permanente Holly Miller, Pharm.D., BCACP, Primary Care Clinical Pharmacist Kaiser Permanente

More information

PBMs: Impact on Cost and Quality of Pharmaceutical Care in the U.S.

PBMs: Impact on Cost and Quality of Pharmaceutical Care in the U.S. Speaker Brian K. Solow, MD, FAAFP Optum Life Sciences Irvine, CA, USA PBMs: Impact on Cost and Quality of Pharmaceutical Care in the U.S. Brian K. Solow, MD, FAAFP Chief Medical Officer, Optum Life Sciences

More information

Adult Immunization Highlights from the 48th National Immunization Conference

Adult Immunization Highlights from the 48th National Immunization Conference Centers for Disease Control and Prevention National Center for Immunization and Respiratory Diseases Adult Immunization Highlights from the 48th National Immunization Conference Amy Parker Fiebelkorn,

More information

Capital Health Plan CMS Star Ratings Strategies for Improvement

Capital Health Plan CMS Star Ratings Strategies for Improvement Capital Health Plan CMS Star Ratings Strategies for Improvement ESTRELLITA REDMON, MD, MBA MEDICAL DIRECTOR The Ultimate Goal Outline Current 5 Star Plans CHP History Importance of Ratings Part C and Part

More information

TREATMENT ADHERENCE OF ASTHMA PATIENTS IN LATVIA AND FACTORS RELATED TO ADHERENCE

TREATMENT ADHERENCE OF ASTHMA PATIENTS IN LATVIA AND FACTORS RELATED TO ADHERENCE Dins Šmits TREATMENT ADHERENCE OF ASTHMA PATIENTS IN LATVIA AND FACTORS RELATED TO ADHERENCE Summary of the Doctoral Thesis for obtaining the degree of a Doctor of Medicine Specialty Medicine Subspecialty

More information

Choosing Life: Empowerment, Action, Results! CLEAR Menu Sessions. Substance Use Risk 5: Drugs, Alcohol, and HIV

Choosing Life: Empowerment, Action, Results! CLEAR Menu Sessions. Substance Use Risk 5: Drugs, Alcohol, and HIV Choosing Life: Empowerment, Action, Results! CLEAR Menu Sessions Substance Use Risk 5: This page intentionally left blank. Session Aims: (70 Minutes) To understand the health consequences of drugs and

More information

Re: Docket No. FDA-2009-N-0294 Regulation of Tobacco Products; Request for Comments

Re: Docket No. FDA-2009-N-0294 Regulation of Tobacco Products; Request for Comments VIA Electronic Submission to http://www.regulations.gov September 29, 2009 Division of Dockets Management (HFA-305) Food and Drug Administration 5630 Fishers Lane, rm. 1061 Rockville, MD 20852 Re: Docket

More information

Taking Medication is No Fun, and That s a Big Problem

Taking Medication is No Fun, and That s a Big Problem Taking Medication is No Fun, and That s a Big Problem Improving Adherence Requires Addressing Psychological Barriers America s Other Drug Problem L & M LAUNDROMAT Nothing But But The The Tooth Tooth DENTISTRY

More information

Mail Order Is Not For Everyone!

Mail Order Is Not For Everyone! Mail Order Is Not For Everyone! Face to face patient counseling by pharmacists can have a powerful impact on long term health care costs and quality. So, the way health plan sponsors promote mail and generics

More information

SURVEY ABOUT YOUR PRESCRIPTION CHOICES

SURVEY ABOUT YOUR PRESCRIPTION CHOICES Editor s Note: This online data supplement contains supplemental material that was not included with the published article by William Shrank and colleagues, Patients' Perceptions of Generic Medications,

More information

Care Management Technologies

Care Management Technologies Care Management Technologies Insight and Action in Behavioral Health Role of MH/DD SA Provider in Improving Care and Lowering Costs: Using Data to Demonstrate Your Value North Carolina Providers Council

More information

Transforming Diabetes Care

Transforming Diabetes Care Transforming Diabetes Care Barriers to Mealtime Insulin Dosing Mark Peyrot, PhD Loyola University Maryland, Baltimore, MD Faculty Background Principle Investigator DAWN and DAWN2 studies (Novo Nordisk)

More information

Robyn Tamblyn, BSCN MSc PhD May 2 nd, 2018 Baldwin Seminar Series Accreditation Council for Graduate Medical Education

Robyn Tamblyn, BSCN MSc PhD May 2 nd, 2018 Baldwin Seminar Series Accreditation Council for Graduate Medical Education Robyn Tamblyn, BSCN MSc PhD May 2 nd, 2018 Baldwin Seminar Series Accreditation Council for Graduate Medical Education Robyn Tamblyn, BScN, MSc, PhD, CM Disclosure None of the above speakers have any conflicts

More information

MOTIVATING BEHAVIOUR CHANGE IN PATIENTS USING OPIOIDS

MOTIVATING BEHAVIOUR CHANGE IN PATIENTS USING OPIOIDS MOTIVATING BEHAVIOUR CHANGE IN PATIENTS USING OPIOIDS Opioid Webinar Series Laura Murphy, PharmD Disclosures No conflict of interest Acknowledgements Andrea Fernandes Anne Kalvik Pearl Isaac Karen Ng Beth

More information

Adherence & Medicaton review

Adherence & Medicaton review Adherence & Medicaton review Assoc. Prof. Mitja Kos, Ph.D., M.Pharm. Head, Chair of Social Pharmacy University of Ljubljana, Faculty of Pharmacy, Web: www.ffa.uni-lj.si E-mail: mitja.kos@ffa.uni-lj.si

More information

Y. W. Francis Lam, Pharm.D. FCCP University of North Texas Health Science Center Grand Round Rx to OTC Switch: Potentials, Challenges, and Initiatives

Y. W. Francis Lam, Pharm.D. FCCP University of North Texas Health Science Center Grand Round Rx to OTC Switch: Potentials, Challenges, and Initiatives 1 Rx to OTC Switch Potentials, Challenges, and Initiatives Y. W. Francis Lam, Pharm.D., FCCP Professor of Pharmacology lamf@uthscsa.edu, 7-8355 Educational Goal Attendees will have an overall understanding

More information

Abstract. Non-Compliance to Antihypertensive Treatment among Patients Attending Prince Zaid Military Hospital

Abstract. Non-Compliance to Antihypertensive Treatment among Patients Attending Prince Zaid Military Hospital Non-Compliance to Antihypertensive Treatment among Patients Attending Prince Zaid Military Hospital Lana Sati Goussous (1) Nashat Ayoub Halasah (1) Manhal Halasa (2) (1) Royal medical Services, Jordan

More information

Lesson 10: Self-Administration of Medication

Lesson 10: Self-Administration of Medication Lesson 10: Self-Administration of Medication Transcript Title Slide (no narration) Welcome Hello. My name is Barbara Breen, Training Coordinator for the Department of Public Welfare Medication Administration

More information

New Mexico Retiree Health Care Authority Medicare Part D Prescription Drug Program Express Scripts Holding Company. All Rights Reserved.

New Mexico Retiree Health Care Authority Medicare Part D Prescription Drug Program Express Scripts Holding Company. All Rights Reserved. New Mexico Retiree Health Care Authority Medicare Part D Prescription Drug Program 1 About Express Scripts Express Scripts is RHCA s chosen partner for administering your prescription plan We are a leading

More information

Calculating Risk for Primary Prevention of Cardiovascular Disease (CVD)

Calculating Risk for Primary Prevention of Cardiovascular Disease (CVD) Calculating Risk for Primary Prevention of Cardiovascular Disease (CVD) 2. Welcome by Stacey Sheridan, MD, MPH Hello. My name is Stacey Sheridan, and I m here as your partner in Heart Health Now. The North

More information

Team-Based Decision Support in Diabetes Outcomes and Costs

Team-Based Decision Support in Diabetes Outcomes and Costs Team-Based Decision Support in Diabetes Outcomes and Costs Session 89, 8:30 a.m. February 13, 2019 Gary Ozanich, Ph.D. - College of Informatics, Northern Kentucky University 1 Conflict of Interest Gary

More information

CONVERSATION STARTERS: ENGAGING YOUR PATIENTS AT PICK UP JULY 12, :00 2:30 PM

CONVERSATION STARTERS: ENGAGING YOUR PATIENTS AT PICK UP JULY 12, :00 2:30 PM CONVERSATION STARTERS: ENGAGING YOUR PATIENTS AT PICK UP JULY 12, 2017 1:00 2:30 PM ACPE UAN: 0107-9999-17-097-L04-P 0.15 CEU/1.5 hr Activity Type: Knowledge-Based Learning Objectives for Pharmacists:

More information

Primary Care Pharmacist Integration and Reimbursement Models

Primary Care Pharmacist Integration and Reimbursement Models Primary Care Pharmacist Integration and Reimbursement Models May 20, 2015 MODERATOR: Marie Smith, PharmD Palmer Professor and Assistant Dean, Practice and Public Policy Partnerships, UConn School of Pharmacy

More information

2/9/2017 DISCLOSURES MOTIVATIONAL INTERVIEWING TO PROMOTE BEHAVIOR CHANGE LEARNING OBJECTIVES WHY PHARMACISTS AND TECHNICIANS

2/9/2017 DISCLOSURES MOTIVATIONAL INTERVIEWING TO PROMOTE BEHAVIOR CHANGE LEARNING OBJECTIVES WHY PHARMACISTS AND TECHNICIANS MOTIVATIONAL INTERVIEWING TO PROMOTE BEHAVIOR CHANGE DISCLOSURES The presenter has no actual or potential conflicts of interest in relation to this presentation. Sarah E. Kelling, PharmD, MPH, BCACP Clinical

More information

3/17/2017. Innovative Opportunities for Pharmacists in the Evolving World of Healthcare. Elderly represent about of our emergency medical services:

3/17/2017. Innovative Opportunities for Pharmacists in the Evolving World of Healthcare. Elderly represent about of our emergency medical services: Innovative Opportunities for Pharmacists in the Evolving World of Healthcare Christina Pornprasert, PharmD Population Health Clinical Pharmacist Hartford Healthcare Integrated Care Partners Addolorata

More information

Adherence with Oral Bisphosphonate Therapy for Osteoporosis Among Patients in Canadian Clinical Practice. Not for Sale or Commercial Distribution

Adherence with Oral Bisphosphonate Therapy for Osteoporosis Among Patients in Canadian Clinical Practice. Not for Sale or Commercial Distribution Adherence with Oral Bisphosphonate Therapy for Osteoporosis Among Patients in Canadian Clinical Practice Nader Habib, MD Heather McDonald-Blumer, MD Michele Moss, MBChB, MCFP Angèle Turcotte, MD Copyright

More information

Innovative Opportunities for Pharmacists in the Evolving World of Healthcare

Innovative Opportunities for Pharmacists in the Evolving World of Healthcare Innovative Opportunities for Pharmacists in the Evolving World of Healthcare Christina Pornprasert, PharmD Population Health Clinical Pharmacist Hartford Healthcare Integrated Care Partners Assistant Clinical

More information

Choosing Life: empowerment, Action, Results! CLEAR Menu Sessions. Adherence 1: Understanding My Medications and Adherence

Choosing Life: empowerment, Action, Results! CLEAR Menu Sessions. Adherence 1: Understanding My Medications and Adherence Choosing Life: empowerment, Action, Results! CLEAR Menu Sessions Adherence 1: Understanding My Medications and Adherence This page intentionally left blank. Understanding My Medications and Adherence Session

More information

Developing a Risk Minimization Action Plan (RiskMAP): Developing Interventions

Developing a Risk Minimization Action Plan (RiskMAP): Developing Interventions Developing a Risk Minimization Action Plan (RiskMAP): Developing Interventions Louis A. Morris, Ph.D. Louis A. Morris & Associates, Inc. www.lamainc.com April 11, 2005 RiskMAP Tools are categorized into

More information

Population Health Management Design: Optimizing the Outcomes for Special Populations 21th Annual ASHP Conference for Pharmacy Leaders

Population Health Management Design: Optimizing the Outcomes for Special Populations 21th Annual ASHP Conference for Pharmacy Leaders Learning objectives Define population health and its impact on pharmacy leaders. Population Health Management Design: Optimizing the Outcomes for Special Populations Meghan D. Swarthout, PharmD, MBA, BCPS

More information

July 30, VIA TO

July 30, VIA  TO July 30, 2012 VIA EMAIL TO DMEPOS@cms.hhs.gov Elliot Klein Centers for Medicare and Medicaid Services 7500 Security Boulevard Mail Stop C5-03-17 Baltimore, MD 21244-1850 RE: Inherent Reasonableness of

More information